Last deal

$25.9M

Amount

Venture - Series Unknown

Stage

30.10.2014

Date

1

all rounds

$25.9M

Total amount

General

About Company
EndoChoice is a medtech company specializing in gastrointestinal diagnosis and treatment.

Industry

Sector :

Subsector :

Keywords :

Also Known As

EndoChoice Holdings, Inc., ECPM

founded date

01.01.2008

Number of employees

Company Type

For Profit

Last funding type

Venture - Series Unknown

IPO status

Private

Description

Headquartered in Alpharetta, Georgia, EndoChoice manufactures and sells a range of products and services for gastrointestinal specialists, including endoscopic imaging systems, devices, infection control products, and pathology services. Their innovative product portfolio includes the Full Spectrum Endoscopy System (Fuse®), which is used in colonoscopy and procedures of the upper GI tract. With a direct sales organization serving over 2,500 customers in the United States and distribution partners in 25 countries, EndoChoice has rapidly grown since its founding in 2008. Their platform technologies are designed to assist specialists in diagnosing and treating various gastrointestinal conditions, including colon cancer.
Contacts

Social url